Frank Yocca

Frank Yocca

Chief Tech/Sci/R&D Officer chez BIOXCEL THERAPEUTICS, INC.

Fortune : 35 992 $ au 31/03/2024

68 ans
Consumer Services
Health Technology
Commercial Services

Profil

Frank D.
Yocca
is a Member of the National Academy of Medicine (United States) and the Chief Scientific Officer & Senior Vice President at BioXcel Therapeutics, Inc. He previously served as the Executive Director at Bristol-Myers Squibb Pharmaceutical Research Institute from 1984 to 2004.
From 2005 to 2015, he worked as the Vice President-Strategy & Externalization at AstraZeneca PLC.
He then joined BioXcel Corp.
as the Senior Vice President-CNS R&D from 2015 to 2017.
Dr. Yocca completed his undergraduate degree at Manhattan College and holds graduate and doctorate degrees from St. John's University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/04/2024 12 763 ( 0,04% ) 35 992 $ 31/03/2024

Postes actifs de Frank Yocca

SociétésPosteDébut
BIOXCEL THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/06/2017
Corporate Officer/Principal -
Tous les postes actifs de Frank Yocca

Anciens postes connus de Frank Yocca

SociétésPosteFin
Corporate Officer/Principal 01/04/2017
ASTRAZENECA PLC Corporate Officer/Principal 01/01/2015
Bristol-Myers Squibb Pharmaceutical Research Institute Director/Board Member 01/01/2004
Voir l'expérience en détail de Frank Yocca

Formation de Frank Yocca

Manhattan College Undergraduate Degree
St. John's University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Frank Yocca

Relations

100 +

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
ASTRAZENECA PLC

Health Technology

Entreprise privées4

Commercial Services

Bristol-Myers Squibb Pharmaceutical Research Institute

Technology Services

BioXcel Therapeutics, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Frank Yocca